Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease

Clinical and Experimental Immunology

Volumn 173, Issue 2, 2013, Pages 250-258

  Iborra, M ^a   Bernuzzi, F ^b   Correale, C ^c   Vetrano, S ^c   Fiorino, G ^c   Beltran B ^a   Marabita, F ^e   Locati, M ^d   Spinelli, A ^c   Nos, P ^a   Invernizzi, P ^b   Danese, S ^c  

^a La Fe University   (Spain)

^b Center for Liver Diseases   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Crohn's disease; inflammation; inflammatory bowel disease; microRNA; ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL FACTOR; COMPLEMENTARY DNA; IMMUNOMODULATING AGENT; MESALAZINE; MICRORNA; MICRORNA 140 3P; MICRORNA 18A; MICRORNA 328; MICRORNA 422A; MICRORNA 629; MICRORNA 885 5P; MICRORNA LET 7B; STEROID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; COHORT ANALYSIS; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; PILOT STUDY; PRIORITY JOURNAL; PROCTITIS; PUNCH BIOPSY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; ULCERATIVE COLITIS;

CROHN'S DISEASE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; MICRORNA; ULCERATIVE COLITIS;

ADULT; DISEASE PROGRESSION; FEMALE; GENETIC MARKERS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MICROARRAY ANALYSIS; MICRORNAS; MIDDLE AGED; TRANSCRIPTOME;

EID: 84880008053     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12104     Document Type: Article

References (43)

1. Liu L, Li Y, Tollefsbol TO. Gene-environment interactions and epigenetic basis of human diseases. Curr Issues Mol Biol 2008; 10:25-36.
2. Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 2008; 263:597-606.
3. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427-434.
4. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9:102-114.
5. Griffiths-Jones S. miRBase: microRNA sequences and annotation. Curr Protoc Bioinformatics 2010; Chapter 12:Unit 12.9.1-10.
6. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39:D152-157.
7. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15-20.
8. Iborra M, Bernuzzi F, Invernizzi P, Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: crucial regulators in immune response. Autoimmun Rev 2012; 11:305-314.
9. Tomankova T, Petrek M, Gallo J etal. MicroRNAs: emerging regulators of immune-mediated diseases. Scand J Immunol 2011 doi: 10.1111/j.1365-3083.2011.02650.x.
10. Chen X, Ba Y, Ma L etal. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18:997-1006.
11. Mitchell PS, Parkin RK, Kroh EM etal. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105:10513-10518.
12. Wang K, Zhang S, Marzolf B etal. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 2009; 106:4402-4407.
13. Tsujiura M, Ichikawa D, Komatsu S etal. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010; 102:1174-1179.
14. Wang GK, Zhu JQ, Zhang JT etal. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31:659-666.
15. Kong X, Du Y, Wang G etal. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci 2011; 56:602-609.
16. Archanioti P, Gazouli M, Theodoropoulos G etal. Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis 2011; 5:520-524.
17. Pekow JR, Kwon JH. MicroRNAs in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18:187-193.
18. Coskun M, Bjerrum JT, Seidelin JB etal. MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18:4629-4634.
19. Wu F, Guo NJ, Tian H etal. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2011; 17:241-250.
20. Zahm AM, Thayu M, Hand NJ etal. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011; 53:26-33.
21. Paraskevi A, Theodoropoulos G, Papaconstantinou I etal. Circulating microRNA in inflammatory bowel disease. J Crohns Colitis 2012; 6:900-904.
22. Wu F, Zikusoka M, Trindade A etal. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008; 135:1624-1635 e24.
23. Fasseu M, Treton X, Guichard C etal. Identification of restricted subsets of mature microRNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS ONE 2010; 5:e13160.
24. Takagi T, Naito Y, Mizushima K etal. Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J Gastroenterol Hepatol 2010; 25 (Suppl. 1):S129-133.
25. Wu F, Zhang S, Dassopoulos T etal. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010; 16:1729-1738.
26. Iborra M, Beltran B, Nos P. [New knowledge in genetics and inflammatory bowel disease. Are there any practical applications?]. Gastroenterol Hepatol 2011; 34:591-598.
27. Dvinge H, Bertone P. HTqPCR: high-throughput analysis and visualization of quantitative real-time PCR data in R. Bioinformatics 2009; 25:3325-3326.
28. Mestdagh P, Van Vlierberghe P, De Weer A etal. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol 2009; 10:R64.
29. Duttagupta R, DiRienzo S, Jiang R etal. Genome-wide maps of circulating miRNA biomarkers for ulcerative colitis. PLoS ONE 2012; 7:e31241.
30. Pauley KM, Satoh M, Chan AL etal. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008; 10:R101.
31. Lindsay MA. microRNAs and the immune response. Trends Immunol 2008; 29:343-351.
32. Brooks WH, Le Dantec C, Pers JO etal. Epigenetics and autoimmunity. J Autoimmun 2010; 34:J207-219.
33. Zhou R, Li X, Hu G etal. miR-16 targets transcriptional corepressor SMRT and modulates NF-kappaB-regulated transactivation of interleukin-8 gene. PLoS ONE 2012; 7:e30772.
34. Della Vittoria Scarpati G, Falcetta F, Carlomagno C etal. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2012; 83:1113-1119.
35. Pekow JR, Dougherty U, Mustafi R etal. miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis 2012; 18:94-100.
36. Ma F, Xu S, Liu X etal. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-gamma. Nat Immunol 2011; 12:861-869.
37. Wang LG, Gu J. Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis. Cancer Epidemiol 2012; 36:e61-67.
38. Huang Z, Huang D, Ni S etal. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010; 127:118-126.
39. Sonkoly E, Pivarcsi A. Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med 2009; 13:24-38.
40. Felli N, Fontana L, Pelosi E etal. MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci USA 2005; 102:18081-18086.
41. Te JL, Dozmorov IM, Guthridge JM etal. Identification of unique microRNA signature associated with lupus nephritis. PLoS ONE 2010; 5:e10344.
42. Piepoli A, Tavano F, Copetti M etal. miRNA expression profiles identify drivers in colorectal and pancreatic cancers. PLoS ONE 2012; 7:e33663.
43. Jude JA, Dileepan M, Subramanian S etal. miR-140-3p regulation of TNF-alpha-induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 2012; 303:L460-468.